Arlington Partners’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,000
Closed -$8K 446
2022
Q2
$8K Hold
2,000
﹤0.01% 393
2022
Q1
$12K Hold
2,000
﹤0.01% 372
2021
Q4
$15K Buy
+2,000
New +$15K ﹤0.01% 424